Search Results - E Askari

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Inducible clindamycin resistance in Staphylococcus aureus isolates recovered from Mashhad, Iran by N Seifi, N Kahani, E Askari, S Mahdipour, M Naderi-Nasab

    Published in Iranian Journal of Microbiology (2012-06-01)
    Get full text
    Article


  2. 2

    P1730: IMPLEMENTATION OF PRO-CTCAE QUESTIONNAIRE IN PROM PROGRAM COLLECTS DIFFERENT ADVERSE EVENTS PROFILE THAN PHYSICIANS AND REDUCE UNSCHEDULED HEALTHCARE IN PATIENTS WITH LYMPHO... by S. RAMOS, E. CASTILLO, N. BARRERAS, M. RIESCO, A. HERRERO, A. PASCUAL, A. LOPEZ, M. A. PEREZ, D. MORILLO, E. ASKARI, E. PRIETO, P. LLAMAS, J. BECARES, C. BARRIOCANAL, M. DEL OLMO, J. SHORT, J. ARCOS, R. CORDOBA

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P10: TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 RE... by N. W. C. J van de Donk, M C Minnema, J G Berdeja, A Oriol, A Krishnan, P Rodríguez-Otero, E Askari, M Mateos, L. J Costa, R Verona, J Ma, S Girgis, S Yang, B. W Hilder, J Russell, J. D Goldberg, A Chari

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  4. 4

    B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY by P Rodriguez-Otero, B Dholaria, E Askari, D Reece, N van de Donk, A Chari, H Goldschmidt, A Krishnan, T Martin, M Mateos, D Morillo, C Rodriguez, L Rosinol, J San-Miguel, A Balari, R Wäsch, K Weisel, R Verona, S Lin, T Prior, M Wade, B Weiss, J Goldberg, A Oriol, P Hari

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  5. 5

    B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS by M Mateos, P Hari, N Bahlis, A Chari, NWCJ van de Donk, B Dholaria, AL Garfall, H Goldschmidt, KM Kortüm, A Krishnan, T Martin, D Morillo, A Oriol, D Reece, C Rodriguez, P Rodríguez-Otero, JF San-Miguel, SZ Usmani, R Verona, SXW Lin, TJ Prior, M Wade, B Weiss, JD Goldberg, E Askari

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  6. 6

    P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)... by M.C. Minnema, A. Chari, C. Touzeau, C. Schinke, J. Berdeja, A. Oriol, de Donk N. van, P.R. Otero, E. Askari, M.V. Mateos, L.J. Costa, J. Caers, L. Rasche, A. Krishnan, D. Vishwamitra, X. Ma, X. Qin, K.S. Gries, M. Campagna, T. Masterson, B. Hilder, J. Tolbert, T. Renaud, J.D. Goldberg, C. Heuck, J.S. Miguel, P. Moreau

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  7. 7

    P42 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISP... by N. van de Donk, L. Rasche, C. Touzeau, A. Chari, C. Schinke, M. Minnema, J. Berdeja, A. Oriol, P. Rodriguez-Otero, E. Askari, M. Mateos, L. Costa, J. Caers, A. Krishnan, D. Vishwamitra, J. Ma, X. Qin, K.S. Gries, K. Kato, M. Campagna, T. Masterson, B. Hilder, J. Tolbert, T. Renaud, J. Goldberg, C. Heuck, P. Moreau, J. San-Miguel

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  8. 8

    S183: NOVEL COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS FOR TALQUETAMAB (A GPRC5D X CD3 BISPECIFIC ANTIBODY) IN CO... by N. W. van de Donk, N. Bahlis, M.-V. Mateos, K. Weisel, B. Dholaria, A. L. Garfall, H. Goldschmidt, T. G. Martin, D. Morillo, D. E. Reece, D. Hurd, P. Rodríguez-Otero, M. Bhutani, A. D’Souza, A. Oriol, E. Askari, J. F. San-Miguel, K. M. Kortüm, D. Vishwamitra, S. Xin Wang Lin, T. J. Prior, L. Vandenberk, M.-A. D. Smit, J. D. Goldberg, R. Wäsch, A. Chari

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: